Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Posted on by Pencis

Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Chongqing Medical University | China

Author Profile

Scopus

ORCID ID

Professor Yinyuan Ding

šŸŒŸ Professor of Oncology
šŸ„ Chongqing Medical University

šŸŽ“ Academic and Professional Background:

Professor Yinyuan Ding obtained a Ph.D. from Peking University in 2011 and pursued postdoctoral training at UT Southwestern Medical Center, where he was later promoted to Assistant Professor in 2018. In 2019, he returned to China and joined Chongqing Medical University as a professor. His research explores tumorigenesis and glucolipid metabolic disorders, focusing on the LRP1 receptor’s role in liver and vascular signaling, with implications for novel treatments for Hepatocellular Carcinoma (HCC) and Metabolic Associated Steatohepatitis-Liver Disease (MASLD).

šŸ”¬ Research and Innovations:

  • Principal Investigator
    2023-2026: “The role of LRP1 in hepatic glucose metabolism and HCC progression” (National Natural Science Foundation of China)
    2021: “The role of Asprosin in hepatocellular carcinoma” (Chongqing Municipal Human Resources Bureau)

 

  • Participant
    2015-2020: “VLDL and ApoE receptors metabolism” (NIH-NHLBI)
    2011-2015: “Cell signaling and cholesterol-lipoprotein receptors” (NIH)

šŸ“š Journals Published:

Advanced Science, Elife, Science Signaling, EBioMedicine, JBC

šŸ¤ Collaborations:

Collaborates with Joachim Herz (UT Southwestern Medical Center, USA)

šŸ‘„ Professional Memberships:

Director of the China Branch, International Atherosclerosis Society

šŸ§¬ Areas of Research:

  • Oncology
  • Tumorigenesis
  • Hepatology
  • Lipoprotein & Lipid Research

šŸ“ Contributions:

Professor Ding’s groundbreaking research on LRP1 has revealed its multifaceted roles in regulating cholesterol and glucose metabolism. His work identified a critical mechanism by which LRP1 affects hepatic insulin resistance, dyslipidemia, and HCC progression. This novel insight into LRP1’s function opens pathways for innovative therapeutic strategies for cancer and metabolic disorders.

āœØConclusion:

In summary, Professor Yinyuan Ding is a distinguished expert in oncology and hepatology, with a strong focus on the molecular mechanisms of tumorigenesis and lipid metabolism disorders. His innovative research on LRP1 has led to significant breakthroughs in understanding liver disease and cancer progression, paving the way for novel therapeutic strategies. With a wealth of experience from top institutions and numerous prestigious publications and patents, Professor Ding continues to make impactful contributions to the field of cancer research, driving advancements in both basic science and clinical applications. šŸŒŸ

šŸ“ŠšŸ”¬NOTABLE PUBLICATION:

1. LRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD-fed mice

  • Authors: Guo, X., Pu, J., Tang, Z., Liu, T., Ding, Y.
  • Journal: Animal Models and Experimental Medicine
  • Year: 2024

2. Erratum: Correction: LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis

  • Authors: Xian, X., Ding, Y., Dieckmann, M., Tsai, S., Herz, J.
  • Journal: eLife
  • Year: 2017 (Erratum published in 2024)

3. Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-ĪŗB Signaling

  • Authors: Guo, X., Yang, F., Liu, T., Herz, J., Ding, Y.
  • Journal: Advanced Science
  • Year: 2024

Prof. Grazia Tamma | Physiology | Best Researcher Award

Posted on by Pencis

Prof. Grazia Tamma | Physiology | Best Researcher Award

University of Bari Aldo Moro | Italy

Author Profile

Scopus

Orcid ID

šŸ‘©ā€šŸ”¬ Grazia Tamma

  • Position: Associate Professor of Physiology (BIO09)
  • Affiliation: Department of Bioscience, Biotechnologies and Pharmacological Science, University of Bari, Italy

šŸŽ“ Education:

  • Degree in Biological Sciences, University of Bari (1999)
  • PhD in Cellular and Molecular Technologies in Physiology (2003)

šŸ”¬ Research Interests:

  • Grazia Tamma’s research focuses on intracellular signal transduction, body and renal water homeostasis, and molecular alterations associated with oxidative stress in health and diseases.

šŸ“š Publications:

  • She has published 86 papers in international scientific journals, 7 book chapters, and presented over 90 abstracts in international meetings.

šŸ† Awards:

  • Recipient of the Italian Society of Physiology Award (2007)

šŸŒ International Collaborations:

  • Collaborates with institutions including FMP Berlin (Germany), University of Innsbruck (Austria), and University of Nijmegen (The Netherlands).

šŸŽ“ Teaching:

  • Teaches physiology at the Department of Biosciences, Biotechnologies and Pharmacological Science, University of Bari.

šŸ” Research Projects:

  • Principal investigator and participant in various national and international research projects focusing on renal physiology and aquaporins.

šŸ“ Grant Responsibilities:

  • Currently leading projects on hyponatremia, nephropathic cystinosis, and sustainable food technologies.

This bio encapsulates Grazia Tamma’s academic journey, research contributions, and professional engagements with relevant titles and emojis.

 

šŸ“ŠšŸ”¬Notable Publication:

Promising Application of Grape Pomace and Its Agri-Food Valorization: Source of Bioactive Molecules with Beneficial Effects

  • Authors: Caponio, G.R., Minervini, F., Tamma, G., Gambacorta, G., De Angelis, M.
    Journal: Sustainability (Switzerland)
  • Year: 2023

 

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer

  • Authors: Tolomeo, D., Traversa, D., Venuto, S., Vacca, A., Storlazzi, C.T.
    Journal: Genes Chromosomes and Cancer
  • Year: 2023

 

AQP2 trafficking in health and diseases: an updated overview

  • Authors: Centrone, M., Ranieri, M., Di Mise, A., Valenti, G., Tamma, G.
    Journal: International Journal of Biochemistry and Cell Biology
  • Year: 2022

 

Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis

  • Authors: Allegretta, C., Difonzo, G., Caponio, F., Tamma, G., Laselva, O.
    Journal: Cells
  • Year: 2023

 

In vivo treatment with calcilytic of CaSR knock-in mice ameliorates renal phenotype reversing downregulation of the vasopressin-AQP2 pathway

  • Authors: Ranieri, M., Angelini, I., D’Agostino, M., Matsumoto, T., Valenti, G.
    Journal: Journal of Physiology
  • Year: 2024

Assoc Prof Dr. Yao Liu | Pharmaceutical | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Yao Liu | Pharmaceutical | Best Researcher Award

Jiangxi University of Science and Technology | China

Author Profile

Scopus

Orcid ID

šŸ§‘ā€šŸ« Yao Liu: Associate Professor of Materials Metallurgy and Chemistry

  • Occupation: Associate Professor, Jiangxi University of Science and Technology, Faculty of Materials Metallurgy and Chemistry

šŸŽ“ Main Responsibilities

  1. NSFC Project Review Expert: Yao Liu serves as a review expert for the National Natural Science Foundation of China (NSFC).
  2. Full-time Faculty Member: Actively involved in teaching and research within the Department of Materials Metallurgy and Chemistry.
  3. Course Instructor: Teaches a variety of undergraduate and graduate courses, including “Professional English,” “Bilingual Functional Materials,” “International Courses (I-III),” “Physical Chemistry Experiment,” “Chemistry Experiment,” “Analytical Chemistry Experiment,” and “Scientific Research Methodology” (graduate all-English course).

šŸ’” Patent

  • Granted Patent No. 202010952941.0: Invention Title: Cesium Chloride Crystal and its Preparation Method and Application.

šŸ† Awards

  • Bronze Award: 6th China International “Internet+” College Student Innovation and Entrepreneurship Competition for the project “Cailiaokexue.com: Create a Payment Platform for Knowledge in Materials Area” (November 2020).

šŸ”¬ Research Projects

  1. NSFC General Program (52162002): Study on Crystallization Behavior and Mechanism of Acid Polymers Co-regulated by Non-photochemical Laser (2022-2025, 350,000 RMB).
  2. NSFC Youth Program (51802129): Study on Crystallization Behavior and Mechanism of Sodium Acetate Induced by Non-photochemical Laser (2018-2021, 260,000 RMB).
  3. Jiangxi Province Teaching Achievement Award Youth Cultivation Project: Reform and Practice of International Talent Training in New Energy Engineering (under review).
  4. Jiangxi Province Youth Science Fund Project (20192BAB216008): Validation of the Intrinsic Mechanism of Non-photochemical Laser-Induced Crystallization (2020-2021, 60,000 RMB).
  5. Jiangxi Province Educational and Teaching Reform Research Project (JXYJG-2022-129): Practice and Exploration of PBL in Graduate Courses in a MOOC Environment (2023-2024, 20,000 RMB).
  6. Ganzhou City Science and Technology Plan Project: Co-regulation of Crystal Growth by Non-photochemical Laser Technology and Acidic Polymers (2020-2021, 60,000 RMB).
  7. University-Enterprise Technology Development Cooperation Project: Purification and Preparation of Cesium Chloride Crystal (2022-2025, 20,000 RMB).
  8. University-level Graduate All-English Course System Construction Project: “Scientific Research Methodology (Information Retrieval)” (2022-2023, 50,000 RMB).
  9. University-level Teaching Quality Engineering Project Textbook: “Applied English Tutorial for Chemistry Majors” (2022-2023, ongoing).

šŸ“œ Certificates

  1. Senior Professional Technical Qualification Certificate: Associate Professor in Higher Education, Jiangxi Province, December 2019.
  2. Intermediate Professional Technical Qualification Certificate: Lecturer in Higher Education, Jiangxi Province, December 2018.
  3. Higher Education Teacher Qualification Certificate: Specializing in English, Jiangxi Provincial Department of Education, September 2020.
  4. High-level Professional Technical Talent: Recognized by Jiangxi Provincial Department of Human Resources, April 2020.

 

šŸ“ŠšŸ”¬Notable Publication:

Enhanced photocatalytic degradation activity via a stable perovskite-type LaFeO3/In2S3 Z-scheme heterostructured photocatalyst: Unobstructed photoexcited charge behavior of Z-scheme photocatalytic system exploration

  • Authors: Han, B., Zhu, P., Liu, Y., Liang, T., Xie, T.
  • Journal: Journal of Alloys and Compounds
  • Year: 2022

 

Para-ferroelectric phase transition induces an excellent second harmonic generation response and a prominent switchable dielectric constant change based on a metal-free ionic crystal

  • Authors: Han, D.-C., Li, Y.-K., Liu, Y., Du, P.-K., Zhang, H.
  • Journal: CrystEngComm
  • Year: 2021

 

Morphology control of laser-induced dandelion-like crystals of sodium acetate through the addition of acidic polymers

  • Authors: Liu, Y., He, H., Liu, Y.
  • Journal: Journal of Applied Crystallography
  • Year: 2021

 

Coupling strong photoluminescence and narrow band gap in a new tetranuclear copper cluster: Copper(I) iodide with dimethylamine

  • Authors: Han, D.-C., Tan, Y.-H., Liu, Y., Zhang, H., Ying, T.-T.
  • Journal: Inorganica Chimica Acta
  • Year: 2021

 

Preparation of ultra-thin sandwich Cu-Cu/CNTs-Cu composite foil with high tensile strength by electrodeposition

  • Authors: Zhang, Y.-S., Liu, Y., Tang, Y.-Z., Shi, H.-J., Du, P.-K.
  • Journal: Journal of Electroanalytical Chemistry
  • Year: 2022

Dr. Jun He | Stem Cell Therapy | Best Researcher Award

Posted on by Pencis

Dr. Jun He | Stem Cell Therapy | Best Researcher Award

The First Affiliated Hospital of Soochow University |Ā  China

Author Profile

Scopus

Dr. Jun He appears to be a highly suitable candidate for the Research for Community Impact Award based on several key factors:

Extensive Professional Experience:

  • Leadership: Dr. He has been the Director of the HLA typing laboratory at the Jiangsu Institute of Hematology since 2010. This role indicates a significant leadership position within an influential research institution.
  • Long-term Commitment: Dr. He has held continuous positions of increasing responsibility at the same institution since 1985, showcasing dedication and consistent contribution to his field.

Educational Background:

  • Dr. He has a robust educational foundation in medicine, with both an M.D. and a B.S. from prestigious institutions in China (Soochow University and Suzhou Medical College).

Impactful Research:

  • Publication Record: Dr. He has published extensively in reputable peer-reviewed journals, with 33 listed publications. These papers cover critical aspects of HLA typing, stem cell transplantation, immunogenetics, and related fields, demonstrating significant contributions to medical science and community health.
  • Research Focus: His research on the genetic loci of HLA, KIRs, and their impact on transplantation outcomes is crucial for improving the success rates and safety of hematopoietic stem cell transplants, a vital area for many patients with hematological malignancies.

Professional Recognition and Membership:

  • Council Memberships: Dr. He has served as a Council Member for both the Experts Committee of the China Marrow Donor Program and The Chinese Medical Society of Organ Transplantation, indicating peer recognition and trust in his expertise.
  • International Membership: His membership in the American Society of Histocompatibility and Immunogenetics shows his engagement with the global scientific community.

Community Impact:

  • Marrow Donor Program: His long-term involvement with the China Marrow Donor Program reflects his commitment to enhancing donor registries and improving transplantation outcomes, directly benefiting patients and the broader community.
  • Training and Mentorship: As a Doctoral Supervisor, Dr. He plays a significant role in training the next generation of medical professionals and researchers, amplifying his impact on community health.

Innovative Research Contributions:

  • NGS and mNGS: His recent work using next-generation sequencing (NGS) and metagenomic NGS for pathogen identification demonstrates his engagement with cutting-edge technologies to improve clinical decision-making and patient outcomes.

In conclusion, Dr. Jun Heā€™s distinguished career, significant research contributions, leadership roles, and dedication to community health make him a highly deserving candidate for the Research for Community Impact Award.

šŸ“ŠšŸ”¬Notable Publication:

    • Authors: Xu, J., Zhou, P., Liu, J., Ma, Y., He, J.
    • Journal: Infectious Diseases and Therapy
    • Year: 2023

 

    • Authors: Jiang, X., Yuan, X., Li, Y., Bao, X., He, J.
    • Journal: HLA
    • Year: 2023

 

    • Authors: Wang, L., Ji, K., Chen, L., Wu, X., He, J.
    • Journal: Frontiers in Immunology
    • Year: 2022

 

    • Authors: Zhou, S., Ma, X., Ma, C., Wu, X., Qin, S.
    • Journal: Bone Marrow Transplantation
    • Year: 2023

 

    • Authors: Cheng, Y., He, J., Zuo, B., He, Y.
    • Journal: Discover Oncology
    • Year: 2024

Excellence in Research Award

Posted on by Pencis

Introduction: Welcome to a realm of innovation and achievement in the world of research! The Excellence in Research Award stands as a beacon, recognizing and honoring those individuals who have propelled the boundaries of knowledge and ushered in a new era of discovery.

Award Eligibility: This distinguished award is open to researchers globally, spanning various fields. Regardless of age, candidates must hold a minimum of a doctoral degree, boast a noteworthy publication history, and have made substantial contributions to their respective fields of study.

Evaluation Criteria: Candidates will be evaluated on the originality, impact, and significance of their research. A robust publication record, innovative methodologies, and contributions that transcend disciplinary boundaries will be key factors in the selection process.

Submission Guidelines: Applicants are required to submit a comprehensive biography, an abstract of their research, and supporting files that illuminate the depth and significance of their work. Submission materials must adhere to specified format guidelines provided in the submission instructions.

Recognition and Community Impact: Beyond individual recognition, this award celebrates the broader impact of research on communities and society. Awardees will be acknowledged in high-profile forums, amplifying the influence of their work within the global research community.

Best Paper Award

Posted on by Pencis

Introduction: Embark on a journey of academic excellence with the Best Paper Award, an accolade designed to recognize and celebrate exceptional contributions to scholarly discourse. This award stands as a testament to the innovative spirit and intellectual prowess of researchers across diverse fields.

Award Eligibility: Open to researchers of all ages globally, the Best Paper Award seeks submissions from individuals who have demonstrated exceptional skill and insight in their respective fields. Eligible candidates should hold a minimum qualification of a master's degree, with a strong emphasis on the quality of their publications.

Evaluation Criteria: Papers will be evaluated based on their originality, depth of research, and impact on the academic community. The selection process considers the significance of the findings, the clarity of presentation, and the potential for the work to influence and advance the relevant field of study.

Submission Guidelines: To be considered for this esteemed award, participants must adhere to detailed submission guidelines. These include providing a comprehensive biography, an abstract of the paper, and supporting files that enhance the understanding of the research conducted.

Recognition and Community Impact: Winners of the Best Paper Award not only receive well-deserved recognition but also contribute to the broader academic community. Their work is highlighted in prestigious forums, fostering collaboration and furthering the impact of their research on global knowledge.

Cancer Research and Advocacy

Posted on by Pencis

Cancer Research and Advocacy

Introduction: Cancer Research and Advocacy stand as pillars in the global effort to combat cancer, addressing both the scientific exploration of this complex disease and the vital support and awareness needed for patients and their families. Together, they strive to improve prevention, early detection, and treatment while championing the rights and well-being of those affected by cancer.

Subtopics in Cancer Research and Advocacy:

Advancements in Cancer Research: Dive into the latest breakthroughs in cancer research, including novel treatment modalities, understanding cancer genetics, and exploring emerging technologies like artificial intelligence in cancer diagnosis and prognosis.

Patient-Centric Care: Explore the advocacy efforts focused on ensuring patients receive the best possible care, including initiatives to enhance access to treatment, improve patient outcomes, and promote a patient-centered healthcare system.

Early Detection and Screening: Investigate the critical role of early detection in cancer survival rates and advocacy campaigns aimed at raising awareness about the importance of regular screenings and diagnostic tools.

Cancer Prevention and Education: Examine initiatives and programs that educate the public about risk factors, lifestyle choices, and preventive measures to reduce the incidence of cancer.

Support and Survivorship: Learn about the various support networks, survivorship programs, and advocacy efforts dedicated to enhancing the quality of life for cancer survivors and their families, addressing emotional, psychological, and practical needs.

Policy and Legislation: Delve into the advocacy work related to cancer-related policies, funding for research, and healthcare legislation, as well as the impact of these policies on cancer patients and research institutions.

Clinical Trials and Access: Explore how advocacy groups work to improve access to clinical trials, promote transparency in research, and advocate for equitable distribution of innovative cancer therapies.

Global Initiatives: Discover international collaborations and organizations dedicated to advancing cancer research and advocacy efforts on a global scale, addressing disparities in cancer care and research across different regions.

Public Awareness Campaigns: Investigate the effectiveness of public awareness campaigns in raising funds, fostering empathy, and reducing stigma associated with cancer, and how these campaigns drive support for research and patient care.

Survivor and Patient Advocacy: Highlight the role of individuals who have experienced cancer firsthand in advocating for policy changes, increased research funding, and improved patient care, and their impact on the cancer community.